C.M. Bidwell & Associates’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-600
Closed -$27K – 455
2020
Q2
$27K Sell
600
-950
-61% -$48.5K 0.02% 281
2020
Q1
$71K Sell
1,550
-635
-29% -$28.7K 0.07% 192
2019
Q4
$94K Sell
2,185
-180
-8% -$7.34K 0.08% 159
2019
Q3
$86K Hold
2,365
– – 0.09% 192
2019
Q2
$111K Buy
+2,365
New +$100K 0.11% 168

Other funds holding ATEX

C.M. Bidwell & Associates's ATEX Position: Q3 2020 in Review

C.M. Bidwell & Associates sold out of Anterix (ATEX) in Q3 2020, closing a stake of 600 shares — an estimated $27K sold.

C.M. Bidwell & Associates first reported a position in ATEX in Q2 2019 and held it in 5 quarters. The position peaked at $111K in Q2 2019. 96 funds tracked by Wall St. Rank hold ATEX as of Q3 2020.

  • C.M. Bidwell & Associates reported no remaining Anterix position as of Q3 2020 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 600 Anterix shares in Q3 2020, an estimated $27K.
  • C.M. Bidwell & Associates first reported a position in Anterix in Q2 2019 and held it in 5 quarters.
  • C.M. Bidwell & Associates's Anterix position peaked at $111K in Q2 2019.
  • 96 funds tracked by Wall St. Rank held Anterix as of Q3 2020.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.